Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kromek is a UK-listed detection technology company that develops and manufactures cadmium zinc telluride (CZT)-based radiation detectors and related bio-detection systems for advanced imaging and CBRN applications. In healthcare, its detector components are supplied to OEM customers for medical imaging systems including SPECT, CT and photon-counting CT, supporting applications such as cancer and Alzheimer's disease imaging. The company also sells commercial radiation detection products for civil nuclear, security screening, homeland security and defence markets. In parallel, Kromek is developing automated airborne pathogen detection and sequencing systems for biodefence and public-health monitoring. Its business model combines detector component supply, product sales, software, custom development and non-exclusive technology licensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kromek.